BIORESTORATIVE THERAPIES, INC. Increase (Decrease) in Derivative Liabilities
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Increase (Decrease) in Derivative Liabilities of -$7.69 million for the 3-month period ending 2023-09-30, per its 10-K/A filed 2024-06-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2024-06-11
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-09-30 was -$7.69M, a 1073.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-06-30 was $2.73M.
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-03-31 was $1.49M, a 56.11% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-09-30 was $790.72K.
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for fiscal 2020 was $2.14M.
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for fiscal 2019 was -$788.97K, a 444.04% decline from fiscal 2018.
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for fiscal 2018 was $229.32K.
- BIORESTORATIVE THERAPIES, INC. increase (decrease) in derivative liabilities for fiscal 2017 was -$107.04K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month | Increase (Decrease) in Derivative Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | -$7.69M 10-K/A · filed 2024-06-11 | -$4.96M derived: sum of 2 quarters · filed 2024-06-11 | -$3.48M 10-K/A · filed 2024-06-11 | ||
| 2023-06-30 | $2.73M 10-K/A · filed 2024-06-11 | $4.22M 10-K/A · filed 2024-06-11 | |||
| 2023-03-31 | $1.49M 10-K/A · filed 2024-06-11 | ||||
| 2022-09-30 | $790.72K 10-K/A · filed 2024-06-11 | -$6.98M derived: sum of 2 quarters · filed 2024-06-11 | -$3.59M 10-K/A · filed 2024-06-11 | ||
| 2022-06-30 | -$7.78M 10-K/A · filed 2024-06-11 | -$4.38M 10-K/A · filed 2024-06-11 | |||
| 2022-03-31 | $3.39M 10-K/A · filed 2024-06-11 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $2.14M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-12 | $0.00 derived: sum of 2 quarters · filed 2021-04-12 | $2.14M 10-Q · filed 2021-04-12 | $1.08M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-12 | $2.14M 10-Q · filed 2021-04-12 | $1.08M derived: sum of 3 quarters · filed 2021-04-30 | $1.15M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2020-03-31 | $2.14M 10-Q · filed 2021-03-29 | $1.08M derived: sum of 2 quarters · filed 2021-04-30 | $1.15M derived: sum of 3 quarters · filed 2021-04-30 | $1.31M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-30 | -$992.28K derived: sum of 2 quarters · filed 2021-04-30 | -$835.23K derived: sum of 3 quarters · filed 2021-04-30 | -$788.97K 10-K · filed 2021-04-30 | |
| 2019-09-30 | $65.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $222.09K derived: sum of 2 quarters · filed 2019-11-13 | $268.35K 10-Q · filed 2019-11-13 | -$59.60K derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-06-30 | $157.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $203.31K 10-Q · filed 2019-08-14 | -$124.64K derived: sum of 3 quarters · filed 2021-03-18 | $490.68K derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-03-31 | $46.26K 10-Q · filed 2019-05-15 | -$281.69K derived: sum of 2 quarters · filed 2021-03-18 | $333.63K derived: sum of 3 quarters · filed 2021-03-18 | $440.41K derived: sum of 4 quarters · filed 2021-03-18 | |
| 2018-12-31 | -$327.95K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $287.37K derived: sum of 2 quarters · filed 2021-03-18 | $394.14K derived: sum of 3 quarters · filed 2021-03-18 | $229.32K 10-K · filed 2021-03-18 | |
| 2018-09-30 | $615.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $722.09K derived: sum of 2 quarters · filed 2018-11-13 | $557.27K 10-Q · filed 2018-11-13 | $465.55K derived: sum of 4 quarters · filed 2019-03-29 | |
| 2018-06-30 | $106.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$58.05K 10-Q · filed 2018-08-14 | -$149.78K derived: sum of 3 quarters · filed 2019-03-29 | -$165.09K derived: sum of 4 quarters · filed 2019-03-29 | |
| 2018-03-31 | -$164.82K 10-Q · filed 2018-05-15 | -$256.55K derived: sum of 2 quarters · filed 2019-03-29 | -$271.86K derived: sum of 3 quarters · filed 2019-03-29 | ||
| 2017-12-31 | -$91.73K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$107.04K derived: sum of 2 quarters · filed 2019-03-29 | -$107.04K 10-K · filed 2019-03-29 | $107.04K 10-K · filed 2018-04-02 | |
| 2017-09-30 | -$15.31K 10-Q · filed 2017-11-14 | -$15.31K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |